Higher levels of smoking also tied to pain-related work limitations and worse self-reported health, mental health
FRIDAY, Oct. 18, 2024 (HealthDay News) — Increased opioid use is seen among adults who smoke cigarettes, according to a study recently published in the American Journal of Preventive Medicine.
William Encinosa, Ph.D., from Georgetown University in Washington, D.C., and colleagues used the Medical Expenditure Panel Survey (2013 to 2021) linked to the National Health Interview Survey to estimate the impact of heavy versus light smoking on opioid use, chronic pain, work limitations due to pain, and poor mental health.
Based on 81,400 adults-years, the researchers found that 37 percent of the population had ever smoked, but they used 69 percent of the nation”s annual prescription opioids. Adults who smoked more than five cigarettes a day constituted 12 percent of the population but used about the same number of opioids as the those who never smoked (63 percent of the population). Compared with adults who currently smoke, adults who formerly smoked used 16 percent fewer opioids (P < 0.01). During the year, the percent with chronic pain varied from 12.2 percent for adults who never smoked to 14.2 percent for light smoking to 16.5 percent for those smoking more than a pack a day (P < 0.01). Severe pain-related work limitations varied from 7.3 percent for adults who never smoked to 16.9 percent for those smoking more than a pack a day (P < 0.01). Compared with never smokers, adults smoking more than a pack a day were twice as likely to report fair or poor mental health (29.2 versus 13.6 percent; P < 0.01).
“As nations deal with the opioid epidemic, integrating smoking cessation programs into substance abuse treatment programs appears prudent,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Withdrawal From Medetomidine Increasingly Seen in ICUs
Financial Incentives Boost Tobacco Abstinence in Underserved Adults
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy
Ultrasound-Guided Hydrodissection Yields Improvements in Carpal Tunnel
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis